• Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: Report from a high level conference 

      Papatheodoridis G., Thomas H.C., Golna C., Bernardi M., Carballo M., Cornberg M., Dalekos G., Degertekin B., Dourakis S., Flisiak R., Goldberg D., Gore C., Goulis I., Hadziyannis S., Kalamitsis G., Kanavos P., Kautz A., Koskinas I., Leite B.R., Malliori M., Manolakopoulos S., Matičič M., Papaevangelou V., Pirona A., Prati D., Raptopoulou-Gigi M., Reic T., Robaeys G., Schatz E., Souliotis K., Tountas Y., Wiktor S., Wilson D., Yfantopoulos J., Hatzakis A. (2016)
      Summary In the WHO-EURO region, around 28 million people are currently living with chronic viral hepatitis, and 120 000 people die every year because of it. Lack of awareness and understanding combined with the social ...
    • Hepatitis a outbreak disproportionately affecting men who have sex with men (MSM) in the european union and european economic area, june 2016 to may 2017 

      Ndumbi P., Freidl G.S., Williams C.J., Mårdh O., Varela C., Avellón A., Friesema I., Vennema H., Beebeejaun K., Ngui S.L., Edelstein M., Smith-Palmer A., Murphy N., Dean J., Faber M., Wenzel J., Kontio M., Müller L., Midgley S.E., Sundqvist L., Ederth J.L., Roque-Afonso A.-M., Couturier E., Klamer S., Rebolledo J., Suin V., Aberle S.W., Schmid D., De Sousa R., Augusto G.F., Alfonsi V., Del Manso M., Ciccaglione A.R., Mellou K., Hadjichristodoulou C., Donachie A., Borg M.-L., Sočan M., Poljak M., Severi E., Parmentier S., Laisnez V., Reynaerts A., Mahieu R., Schirvel C., Vestergaard H.T., Nisavanh A., Jessen H., Michaelis K., Sissolak D., Thoulass J., Zimmermann R., Thornton L., Martinelli D., Cappelli M.G., Del Matto G., Chironna M., Bruni R., Borg M.-L., Aldir I., Nascimento M., Martins A., Aguiar B., Medina D., Fafangel M., Skaza A.T., Marinko J.S., Stojanovič D., Kurinčič T.S., Montaño-Remacha C., Fernandez M.G., Gomez-Barroso D., Vazquez S., Reyes N., Mandal S., Balogun K., Spiteri G., Takkinen J., Amato A., European Hepatitis A Outbreak Investigation Team (2018)
      Between 1 June 2016 and 31 May 2017, 17 European Union (EU) and European Economic Area countries reported 4,096 cases associated with a multi-country hepatitis A (HA) outbreak. Molecular analysis identified three co-circulating ...
    • Impact of the financial crisis on COPD burden: Greece as a case study 

      Kotsiou O.S., Zouridis S., Kosmopoulos M., Gourgoulianis K.I. (2018)
      Poverty and low socioeconomic status have been associated with chronic obstructive pulmonary disease (COPD). The current financial crisis has forced millions back into poverty. Greece is one of the countries hit the hardest, ...
    • International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency 

      Farkas H., Martinez-Saguer I., Bork K., Bowen T., Craig T., Frank M., Germenis A.E., Grumach A.S., Luczay A., Varga L., Zanichelli A., HAWK, Aberer W., Andrejevic S., Aygoeren-Pürsün E., Banerji A., Bara N.-A., Bas M., Bernstein J., Betschel S., Björkander J., Boccon-Gibod I., Bouillet L., Bova M., Boysen H.H., Branco-Ferreira M., Bygum A., Caballero T., Cancian M., Castaldo A., Christiansen S., Cicardi M., Drouet C., Fabiani J., Gompels M., Gonzalez-Quevedo M.T., Gooi J., Gower R., Gökmen N.M., Grivcheva-Panovska V., Guilarte M., Gülbahar O., Hack E., Hakl R., Harmat G., Jeseňák M., Jolles S., Kaplan A., Katelaris C., Kosnik M., Kőhalmi K.V., Leibovich I., Levi M., Li H., Longhurst H.J., Lumry W., Magerl M., Malbran A., Martin L., Maurer M., Mihály E., Moldovan D., Murdjeva M., Nagy I.B., Nielsen E.W., Nieto S., Nordenfelt P., Obtulowitzc K., Pedrosa M., Porębski G., Prior N., Reshef A., Riedl M.A., Rosenkranz B., Schmid-Grendelmeier P., Péter S., Speletas M., Staevska M., Stobiecki M., Triggiani M., Veszeli N., Wuillemin W., Xiang Z.Y., Yamamoto B., Zuraw B. (2017)
      Background: The consensus documents published to date on hereditary angioedema with C1 inhibitor deficiency (C1-INH-HAE) have focused on adult patients. Many of the previous recommendations have not been adapted to pediatric ...
    • Left ventricular hypertrophy and sudden cardiac death 

      Giamouzis G., Dimos A., Xanthopoulos A., Skoularigis J., Triposkiadis F. (2022)
      Sudden cardiac death (SCD) is among the leading causes of death worldwide, and it remains a public health problem, as it involves young subjects. Current guideline-directed risk stratification for primary prevention is ...
    • New prophylaxis strategies to reduce the risk of thromboembolism in cancer 

      Papadopoulos V., Tsapakidis K., Markou A., Kokkalis A., Aidarinis C., Kotsakis A. (2021)
      Introduction: Patients with cancer are at risk of thrombotic events, mainly deep vein thrombosis and/or pulmonary embolism. The thrombosis risk is generally 4–6 times higher than in a healthy population and depends on ...
    • Physical activity and hypertension: an overview 

      Rontoyannis, G. P. (2005)
    • Prevention and screening for colorectal cancer 

      Tsakiridou, I.; Argyriou, K.; Hatzitolios, A. (2010)
      Colorectal cancer is one of the most common cancers worldwide. It is related to adoption of the western way of life and in the majority of cases, excluding the hereditary type, it appears to be more common in elderly people. ...
    • Statin-based therapy for primary and secondary prevention of ischemic stroke: A meta-analysis and critical overview 

      Milionis H., Ntaios G., Korompoki E., Vemmos K., Michel P. (2020)
      Background and aims: To reassess the effect of statin-based lipid-lowering therapy on ischemic stroke in primary and secondary prevention trials with regard to achieved levels of low-density lipoprotein-cholesterol in view ...